For us, it’s personal. At Imago, we are committed to finding new ways to treat myeloproliferative neoplasms – diseases which pose great challenges to patients, their families and treating physicians. We are dedicated to focusing on areas of serious clinical need, where our unique insights into the relationship between normal blood cell development and disease can be translated into new treatments for serious or life-threatening diseases. Our team is made up of seasoned scientists, physicians and life science professionals who see promise for patients through the lens of science.